Artiva Biotherapeutics, Inc. (ARTV)

SEC filing

Artiva Biotherapeutics, Inc.

ARTV · CIK 1817241

4 · Sep 14, 2026 · Director, 10% Owner Shah Rajeev M. was granted 16.25K Director Stock Option (Right to Buy)

Director, 10% Owner Shah Rajeev M. was granted 16.25K Director Stock Option (Right to Buy)

xslF345X06/form4-09142026_100941.xml

xslF345X06/form4-09142026_100941.xmlSEC.gov

Graphics and non-inline formats (not embedded below).